Sani M - Search Results

1

Novel pyrazole derivatives as neutral CB₁ antagonists with significant activity towards food intake.

Manca I, Mastinu A, Olimpieri F, Falzoi M, Sani M, Ruiu S, Loriga G, Volonterio A, Tambaro S, Bottazzi ME, Zanda M, Pinna GA, Lazzari P. Manca I, et al. Among authors: sani m. Eur J Med Chem. 2013 Apr;62:256-69. doi: 10.1016/j.ejmech.2012.12.056. Epub 2013 Jan 11. Eur J Med Chem. 2013. PMID: 23357307

2

A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives.

Lazzari P, Distinto R, Manca I, Baillie G, Murineddu G, Pira M, Falzoi M, Sani M, Morales P, Ross R, Zanda M, Jagerovic N, Pinna GA. Lazzari P, et al. Among authors: sani m. Eur J Med Chem. 2016 Oct 4;121:194-208. doi: 10.1016/j.ejmech.2016.05.011. Epub 2016 May 6. Eur J Med Chem. 2016. PMID: 27240274

3

Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy.

Tseng CC, Noordali H, Sani M, Madhani M, Grant DM, Frenneaux MP, Zanda M, Greig IR. Tseng CC, et al. Among authors: sani m. J Med Chem. 2017 Apr 13;60(7):2780-2789. doi: 10.1021/acs.jmedchem.6b01592. Epub 2017 Mar 21. J Med Chem. 2017. PMID: 28277663 Free article.

4

Synthesis and structure-activity relationship studies of novel tubulysin U analogues--effect on cytotoxicity of structural variations in the tubuvaline fragment.

Shankar SP, Jagodzinska M, Malpezzi L, Lazzari P, Manca I, Greig IR, Sani M, Zanda M. Shankar SP, et al. Among authors: sani m. Org Biomol Chem. 2013 Apr 14;11(14):2273-87. doi: 10.1039/c3ob27111k. Org Biomol Chem. 2013. PMID: 23411563

5

Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on Tubuvaline.

Sani M, Lazzari P, Folini M, Spiga M, Zuco V, De Cesare M, Manca I, Dall'Angelo S, Frigerio M, Usai I, Testa A, Zaffaroni N, Zanda M. Sani M, et al. Chemistry. 2017 Apr 27;23(24):5842-5850. doi: 10.1002/chem.201700874. Epub 2017 Apr 12. Chemistry. 2017. PMID: 28300330

6

Development of novel ADCs: conjugation of tubulysin analogues to trastuzumab monitored by dual radiolabeling.

Cohen R, Vugts DJ, Visser GW, Stigter-van Walsum M, Bolijn M, Spiga M, Lazzari P, Shankar S, Sani M, Zanda M, van Dongen GA. Cohen R, et al. Among authors: sani m. Cancer Res. 2014 Oct 15;74(20):5700-10. doi: 10.1158/0008-5472.CAN-14-1141. Epub 2014 Aug 21. Cancer Res. 2014. PMID: 25145670

7

KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation.

Lazzari P, Spiga M, Sani M, Zanda M, Fleming IN. Lazzari P, et al. Among authors: sani m. Hypoxia (Auckl). 2017 May 23;5:45-59. doi: 10.2147/HP.S132832. eCollection 2017. Hypoxia (Auckl). 2017. PMID: 28580362 Free PMC article.

8

Synthesis and in vitro Evaluation of Trifluoroethylamine Analogues of Enkephalins.

Sinisi R, Ghilardi A, Ruiu S, Lazzari P, Malpezzi L, Sani M, Pani L, Zanda M. Sinisi R, et al. Among authors: sani m. ChemMedChem. 2009 Sep;4(9):1416-20. doi: 10.1002/cmdc.200900158. ChemMedChem. 2009. PMID: 19533725 No abstract available.

9

The trifluoroethylamine function as peptide bond replacement.

Sani M, Volonterio A, Zanda M. Sani M, et al. ChemMedChem. 2007 Dec;2(12):1693-700. doi: 10.1002/cmdc.200700156. ChemMedChem. 2007. PMID: 17823898 Review. No abstract available.

10

Synthesis of Orthogonally Protected Labionin.

Lo Presti E, Volonterio A, Sani M. Lo Presti E, et al. Among authors: sani m. J Org Chem. 2021 Mar 5;86(5):4313-4319. doi: 10.1021/acs.joc.0c02922. Epub 2021 Feb 18. J Org Chem. 2021. PMID: 33599506 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

636 results

Search Page